Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹2,376Cr
Rev Gr TTM
Revenue Growth TTM
-10.65%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

TIRUMALCHM
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -26.1 | -15.8 | -5.2 | -3.2 | 22.2 | 6.1 | -3.1 | -9.2 | -0.7 | -18.9 | -15.2 | -6.9 |
| 432 | 485 | 527 | 498 | 523 | 524 | 502 | 467 | 508 | 477 | 449 | 431 |
Operating Profit Operating ProfitCr |
| -0.2 | 7.2 | 2.9 | -1.2 | 0.7 | 5.5 | 4.5 | -4.5 | 2.8 | -5.9 | -0.8 | -3.6 |
Other Income Other IncomeCr | 11 | 5 | 6 | 4 | 4 | 3 | 9 | 0 | 8 | 2 | 8 | 4 |
Interest Expense Interest ExpenseCr | 7 | 10 | 10 | 12 | 10 | 9 | 10 | 14 | 15 | 18 | 26 | 21 |
Depreciation DepreciationCr | 16 | 16 | 16 | 15 | 17 | 14 | 13 | 16 | 18 | 22 | 23 | 23 |
| -13 | 17 | -4 | -29 | -19 | 11 | 9 | -50 | -11 | -64 | -44 | -55 |
| 0 | 6 | 2 | -6 | 2 | 6 | 4 | -8 | 3 | -4 | -10 | -9 |
|
Growth YoY PAT Growth YoY% | -114.3 | -82.3 | -117.5 | -376.8 | -59.4 | -52.2 | 181.5 | -82.9 | 31.3 | -1,278.0 | -782.6 | -10.8 |
| -3.0 | 2.0 | -1.1 | -4.7 | -3.9 | 0.9 | 0.9 | -9.4 | -2.7 | -13.3 | -7.5 | -11.2 |
| -1.3 | 1.0 | -0.6 | -2.2 | -2.0 | 0.5 | 0.5 | -4.1 | -1.4 | -5.9 | -3.1 | -3.9 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -11.9 | 8.9 | 27.6 | -3.9 | -14.0 | 0.1 | 84.0 | 6.7 | -2.3 | -1.6 | -10.5 |
| 1,035 | 846 | 871 | 1,022 | 1,055 | 1,007 | 865 | 1,557 | 1,946 | 2,032 | 2,001 | 1,865 |
Operating Profit Operating ProfitCr |
| 3.5 | 10.4 | 15.3 | 22.1 | 16.3 | 7.2 | 20.3 | 22.1 | 8.7 | 2.5 | 2.4 | -1.7 |
Other Income Other IncomeCr | 8 | 5 | 4 | 7 | 12 | 21 | 7 | 12 | 30 | 19 | 21 | 22 |
Interest Expense Interest ExpenseCr | 35 | 23 | 17 | 13 | 12 | 17 | 21 | 20 | 31 | 42 | 49 | 81 |
Depreciation DepreciationCr | 18 | 25 | 36 | 31 | 36 | 44 | 50 | 57 | 56 | 63 | 61 | 85 |
| -7 | 55 | 109 | 253 | 169 | 38 | 157 | 375 | 129 | -35 | -41 | -174 |
| 7 | 23 | 39 | 83 | 55 | 15 | 39 | 94 | 40 | 4 | 5 | -20 |
|
| | 334.3 | 119.8 | 141.2 | -33.4 | -79.6 | 407.9 | 139.0 | -68.1 | -143.2 | -18.9 | -234.0 |
| -1.3 | 3.4 | 6.9 | 13.0 | 9.0 | 2.1 | 10.8 | 14.1 | 4.2 | -1.9 | -2.3 | -8.4 |
| -1.3 | 3.1 | 6.9 | 1.7 | 11.1 | 2.3 | 11.5 | 27.5 | 8.8 | -3.8 | -4.5 | -14.2 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 12 |
| 183 | 208 | 388 | 563 | 658 | 628 | 793 | 1,075 | 1,182 | 1,136 | 1,145 | 1,521 |
Current Liabilities Current LiabilitiesCr | 287 | 251 | 327 | 144 | 328 | 301 | 301 | 555 | 866 | 1,029 | 926 | 938 |
Non Current Liabilities Non Current LiabilitiesCr | 66 | 50 | 61 | 108 | 145 | 261 | 239 | 221 | 303 | 1,145 | 1,725 | 1,874 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 281 | 227 | 370 | 338 | 459 | 499 | 573 | 1,031 | 1,053 | 1,134 | 961 | 1,094 |
Non Current Assets Non Current AssetsCr | 266 | 294 | 417 | 487 | 681 | 701 | 770 | 831 | 1,308 | 2,186 | 2,846 | 3,251 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 153 | 126 | 108 | 81 | 234 | 140 | 221 | 402 | 54 | 237 | -66 |
Investing Cash Flow Investing Cash FlowCr | -20 | -32 | -44 | -54 | -220 | -38 | -157 | -139 | -359 | -831 | -542 |
Financing Cash Flow Financing Cash FlowCr | -141 | -93 | -52 | -16 | 16 | 46 | -38 | -70 | 206 | 643 | 375 |
|
Free Cash Flow Free Cash FlowCr | 131 | 98 | 85 | 22 | 41 | 38 | 221 | 402 | 55 | 237 | -64 |
| -1,114.3 | 390.9 | 153.0 | 47.4 | 206.0 | 602.8 | 187.6 | 143.1 | 60.3 | -611.1 | 142.9 |
CFO To EBITDA CFO To EBITDA% | 407.0 | 128.5 | 68.6 | 27.9 | 113.6 | 178.9 | 100.0 | 91.3 | 29.1 | 464.6 | -135.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 83 | 184 | 906 | 1,749 | 910 | 361 | 875 | 2,724 | 1,760 | 2,397 | 2,487 |
Price To Earnings Price To Earnings | 0.0 | 6.1 | 12.8 | 10.3 | 8.0 | 15.6 | 7.4 | 9.7 | 19.6 | 0.0 | 0.0 |
Price To Sales Price To Sales | 0.1 | 0.2 | 0.9 | 1.3 | 0.7 | 0.3 | 0.8 | 1.4 | 0.8 | 1.1 | 1.2 |
Price To Book Price To Book | 0.4 | 0.8 | 2.3 | 3.0 | 1.4 | 0.6 | 1.1 | 2.5 | 1.5 | 2.1 | 2.1 |
| 5.1 | 2.4 | 5.7 | 6.0 | 4.5 | 4.2 | 3.4 | 5.3 | 9.3 | 59.8 | 80.2 |
Profitability Ratios Profitability Ratios |
| 20.7 | 30.4 | 34.4 | 40.4 | 34.3 | 28.4 | 40.2 | 40.0 | 28.2 | 20.1 | 22.6 |
| 3.5 | 10.4 | 15.3 | 22.1 | 16.3 | 7.2 | 20.3 | 22.1 | 8.7 | 2.5 | 2.4 |
| -1.3 | 3.4 | 6.9 | 13.0 | 9.0 | 2.1 | 10.8 | 14.1 | 4.2 | -1.9 | -2.3 |
| 9.0 | 27.4 | 29.4 | 42.7 | 24.3 | 6.7 | 18.1 | 31.7 | 9.4 | 0.3 | 0.3 |
| -7.1 | 14.7 | 17.8 | 29.8 | 17.0 | 3.6 | 14.7 | 25.9 | 7.5 | -3.4 | -4.0 |
| -2.5 | 6.2 | 9.0 | 20.7 | 9.9 | 1.9 | 8.8 | 15.1 | 3.8 | -1.2 | -1.2 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Thirumalai Chemicals Limited (TCL), founded in 1944 as a chemical trading firm and incorporated as a manufacturer in 1973, is a leading Indian specialty and industrial chemical company with a growing global footprint. Headquartered in Mumbai, TCL has evolved into a vertically integrated, technologically advanced chemical manufacturer with operations across India, Southeast Asia, Europe, and an upcoming facility in the United States. The company serves over 650 global customers across more than 60 countries in key sectors including food, pharmaceuticals, paints, plastics, agrochemicals, and consumer goods.
With a strong focus on innovation, sustainability, and strategic expansion, TCL is transitioning toward higher-margin, value-added products while reinforcing its leadership in core commodity chemicals.
---
### **Core Products & Business Segments**
TCL produces a diversified portfolio of industrial and specialty chemicals:
- **Phthalic Anhydride (PA):** World’s largest single-train PA plant (100 KTPA) in Dahej; total PA capacity of ~327,000 TPA (Ranipet: 199 KTPA, Dahej: 128 KTPA). Used in plasticizers, UPR resins, paints, dyes, and construction materials.
- **Maleic Anhydride (MAn):** Produced in Ranipet (India) and Malaysia (50 KTPA). Serves automotive, aerospace, coatings, and composites.
- **Food & Pharma-Grade Acids:**
- **Fumaric Acid:** Sole producer in India; used in food, pharma, and industry.
- **Malic Acid:** Only producer in India and Southeast Asia; key acidulant in food and beverages (supplies global clients like Perfetti, Symrise).
- **Diethyl Phthalate (DEP):** High-solvency plasticizer used in fragrances, cosmetics, and insect repellents.
- **Ethanol & o-Xylene:** Supporting derivatives and internal processes.
The company produces over 8 chemical products and is recognized as one of the few Indian producers with global-grade certifications for food and pharma-grade Maleic Anhydride and related derivatives.
---
### **Global Manufacturing Footprint**
#### **India**
- **Ranipet, Tamil Nadu (Est. 1973):** Flagship facility producing Phthalic Anhydride, Fumaric Acid, Malic Acid, DEP, and ethanol. Home to the newly established **TCL Technology and Engineering** division for modular plant construction.
- **Dahej, Gujarat (Est. 2021):** World-class, fully automated, IoT-enabled facility operated via subsidiary **TCL Intermediates Pvt. Ltd.**, producing 128 KTPA PA and 10 KTPA Fumaric Acid. Located near demand hubs (60–80% of Indian customers within 250 km) and raw material sources. Fully commissioned and stabilizing by H1 FY26.
#### **Malaysia**
- **Optimistic Organic Sdn Bhd (OOSB):** 50 KTPA Maleic Anhydride plant, established via acquisition in 2012. Strategic hub for ASEAN and Middle East markets. Facing margin pressures due to Chinese oversupply; management exploring strategic options, including divestment.
#### **United States**
- **TCL Specialties LLC (New Martinsville, West Virginia):** Fully integrated, modularly constructed plant under construction. Will produce:
- **40,500+ TPA Maleic Anhydride**
- **30,000 TPA Food Ingredients (Malic & Fumaric Acid)**
- **Start-up Target:** October–December 2025 (FY26), with full commercial operations by CY2026.
- **Key Advantages:**
- Low-cost **n-butane feedstock** (25% cheaper than Asia due to proximity to Appalachian shale gas).
- **Fully backward-integrated** with self-generated energy (80% heat reuse from MAn process).
- Modular construction from India’s Ranipet SEZ reduced capital cost and enabled faster deployment.
- Expected **payback <7 years**.
- Over **53% of U.S. volume growth** expected in non-commodity/value-added chemicals.
---
### **Strategic Initiatives & Competitive Edge**
#### **1. U.S. Market Entry – High-Growth Opportunity**
- **Import-Dependent Markets:** 65–70% of U.S. demand for Malic and Fumaric Acid is currently imported.
- Strategic location within **1,000 miles of 40% of North American MAn customers** and near port/transport infrastructure.
- Positioned to replace Asian imports facing high logistics costs and tariff risks.
- Only limited competition expected from existing U.S. MAn producer due to lack of backward integration.
- High barriers to entry for new players due to capital intensity and feedstock dependency.
#### **2. Modular “Build in India for USA” Strategy**
- Entire plant constructed in **Special Economic Zone (SEZ)** in Ranipet, shipped and assembled in West Virginia.
- Reflects successful execution of **“Make in India”** and de-risked project delivery.
- Offers cost control, quality assurance, and faster commissioning.
#### **3. Vertical Integration & Proprietary Technology**
- **Backward integration** into feedstocks (o-xylene, butane) ensures cost competitiveness.
- **In-house developed technologies** for MAn, Malic Acid, Fumaric Acid, and DEP.
- Holds **global patents** for efficient Maleic Anhydride production and by-product recovery.
- Recovers **Maleic Anhydride, Benzoic Acid, and Fumaric Acid** from waste streams—turning waste into revenue.
#### **4. R&D & Innovation**
- Dedicated **R&D center in Ranipet** with pilot plant, automation, and IoT integration.
- 8-member team; R&D spend of ₹2.4 crore (FY23–24), increasing in FY24–25.
- Focus on **sustainability, process efficiency, new formulations**, and **eco-friendly packaging**.
- Two new specialty products in development for commercialization within 5 years.
---
### **Financials & Investment Update (FY25–26)**
- **FY25 Revenue:** ₹2,050 Crore
- **Market Share:** ~37% of domestic PA market; leading global PA and Fumaric Acid producer.
- **Exports:** ~6% of turnover (previously ~12%), with deliberate shift toward North America due to margin pressures in Europe.
- **Capital Expenditure:**
- **U.S. Project:** ~$240 million (entirely funded through internal accruals and debt taken 2.5 years ago).
- **Dahej Project:** ₹750 Crore; fully funded via internal cash flows.
- **Debt Status:** Took on first debt for Dahej and U.S. projects but maintains conservative financial policy.
- **No Debt at Peak:** Debt-free status briefly achieved 18 months ago.
---
### **Operations & Supply Chain**
- **Global Presence:** 4 manufacturing plants, subsidiaries in Malaysia, Singapore, USA, Netherlands (TCL Global B.V.), and UK.
- **TCL Global B.V. (Netherlands):** European distribution hub. Profits in FY23; enhances margins, compliance (REACH), and service delivery.
- **Logistics Efficiency:**
- Dahej reduces Scope 3 emissions and cuts delivery times for Western India.
- Modular construction slashes project timelines and costs.
- **Sustainability Commitments:**
- Zero wastewater discharge; emission scrubbing.
- Circular economy practices: by-product recovery and waste-to-value conversion.
- CSR through **Thirumalai Charity Trust** (women’s empowerment, healthcare, education since 1983).
---
### **Management & Governance**
- **Leadership Transition:**
- **Mr. CG Sethuram:** Former CEO, now focused on strategic growth and new ventures.
- **Mr. Sanjay Sinha:** Appointed CEO (2021) with extensive global business experience.
- **Global Teams:** Building cross-cultural, international management teams; hiring locally in the U.S.; training Indian personnel for global roles.
- **Operational Resilience:** Demonstrated agility during pandemic, Ukraine war, and supply chain disruptions via alternate sourcing and operational flexibility.